UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form SD

SPECIALIZED DISCLOSURE REPORT

Abbott
Laboratories

(Exact Name of Registrant as Specified in Charter)

Hubert Allen                       (224) 668-6856

(Name and telephone number, including area code, of the person to contact in connection with this report.)

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

x Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2014.

Section 1 - Conflict Minerals Disclosure

Item 1.01 Conflict Minerals Disclosure and Report

Abbott Laboratories (Abbott) is filing a Conflict Minerals Report as an exhibit to this specialized disclosure report and is providing that report on Abbott’s publicly available Internet website at http://www.abbott.com/policies/conflict-minerals.html.

Abbott’s determination and related disclosures relating to materials that may come from recycled and scrap sources are included in our Conflict Minerals Report and are incorporated by reference herein.

Item 1.02 Exhibit

The Conflict Minerals Report required by Item 1.01 is filed as an exhibit to this Form SD.

Section 2 — Exhibits

Item 2.01 Exhibits

The following exhibit is filed as a part of this report.

Exhibit 1.01 - Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

Abbott Laboratories

(Registrant)

3

EXHIBIT INDEX

Exhibit 1.01                              Conflict Minerals Report for the Year Ended December 31, 2014

4

Exhibit 1.01

Abbott Laboratories

Conflict Minerals Report

For the Year Ended December 31, 2014

This report for the year ended December 31, 2014 has been prepared by Abbott Laboratories and its consolidated subsidiaries, as context requires (herein referred to as “Abbott,” “we,” “us,” or “our”) and is submitted in accordance with Rule 13p-1 of the Securities Exchange Act of 1934 (the Rule), and regulations and guidance issued by the Securities and Exchange Commission (SEC) relating to the Rule. This report is available on our website at http://www.abbott.com/policies/conflict-minerals.html.

1.                                      Overview

Abbott is a broad-based, global health care company. We discover, develop, manufacture and market a wide range of health care products, including nutritional products, diagnostic systems and tests, branded generic pharmaceuticals and medical devices.

We analyzed the products we manufacture or contract to have manufactured, and found that small quantities of tin, tantalum, tungsten, and gold (3TG) may be present in a number of our products; primarily, in electronic diagnostic and monitoring instruments, in medical and surgical devices and equipment, and in product components containing metal alloys. After requesting information from our suppliers as described below, we are unable to determine whether the limited quantities of 3TG actually present in our products originated from the Democratic Republic of the Congo or adjoining countries, and whether such 3TG came from recycled or scrap sources. We similarly have been unable to conclusively identify the specific facilities used to process the 3TG actually present in our products.

Supply Chain

Abbott manufactures thousands of products. Because of the diversity and complexity of our products, we have thousands of suppliers that supply us with parts, components or other materials. Each of these suppliers may in turn have large numbers of sub-suppliers. We typically do not have direct relationships with mines, smelters or refiners. We rely on our suppliers to provide information on the origin of 3TG contained in the parts, components and materials supplied to us — including sources of 3TG that are supplied to them from their lower-tier suppliers. Many of our smaller suppliers, as well as those further upstream in the supply chain, are not SEC registrants subject to the Rule.

Our contracts with direct suppliers may be in force for multiple years and historically did not require the supplier to provide Abbott with information regarding the origin of 3TG. As we renew or enter into new contracts with suppliers for parts, components or other materials that may contain 3TG, we are working to add language requiring those suppliers to provide information about the source and chain of custody of 3TG present in the parts, components and materials they supply to Abbott. While these supplier contracts are being updated to contain appropriate flow-down provisions, we must rely on the cooperation of our direct suppliers to provide the necessary information on the origin of 3TG and are continuing to work with our suppliers to obtain current 3TG sourcing information, as described in more detail below.

Requesting Information from Suppliers

Abbott’s supplier query program was designed to first survey direct suppliers who provide parts, components or materials likely to contain 3TG. Abbott also surveyed certain sub-suppliers with whom we have no direct relationship, but who sell parts, components or materials to distributors who sell directly to Abbott.

1

We surveyed identified suppliers, as described above, using the Conflict Minerals Reporting Template (CMRT) developed by the Conflict Free Sourcing Initiative (CFSI). The CMRT was developed to facilitate disclosure and communication of information regarding smelters that provide material to a manufacturer’s supply chain and forms a basis for our Reasonable Country of Origin Inquiry (RCOI). The CMRT includes questions regarding the supplier’s “conflict-free policy,” its engagement with its direct upstream suppliers, and a listing of smelters used. In addition, the CMRT contains questions about the origin of 3TG included in the supplier’s products, as well as the respondent’s due diligence on their suppliers. Written instructions and recorded training on the CMRT is available on the CFSI website.

2.                                      Design of Due Diligence Process

Abbott’s due diligence measures have been designed to conform in all material respects with the framework set forth in the OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas (OECD Guidance) and the related Supplements for gold and for tin, tantalum and tungsten. Below is a description of the measures that we implemented and the diligence we performed.

3.                                      Description of Due Diligence Performed

The due diligence measures we performed are presented below according to the five-step framework established by the OECD.

3.1                               Company Management Systems

Communication

Our company statement relating to conflict minerals is available on our website at: http://www.abbott.com/policies/conflict-minerals.html.

Internal Management Structure

We established an internal management structure and processes to support supply chain due diligence related to 3TG. This includes a cross-functional conflict minerals steering committee sponsored by senior management, as well as sub-teams focused on development, implementation, and ongoing enhancements to our compliance processes. The sub-teams include management representatives and subject matter experts from each of our operating divisions, as well as representatives from Legal, Quality Assurance, Purchasing, Finance, Government Affairs and Public Affairs. Senior management was briefed on the results of our supplier due diligence efforts.

System of Controls and Transparency

Through our membership in the CFSI we actively follow and support national and international efforts to identify upstream actors in the supply chain and increase traceability.

We have established various supplier controls, including our Supplier Guidelines, which outline expected behaviors and practices for our suppliers, and our Code of Business Conduct, which outlines Abbott’s core values and expectations for Abbott employees.

Abbott has established procedures and control systems to ensure relevant documentation are retained for an appropriate time period.

Supplier Engagement

Abbott has developed model contract language requiring suppliers to provide adequate information regarding the source and chain of custody of 3TGs. We are working to add this language to

2

agreements where the supplier is providing parts, components, assemblies, materials or other products that may contain any 3TGs. Our Supplier Guidelines also include expectations for suppliers regarding the tracking and reporting of conflict minerals in the parts, components or materials they supply to Abbott.  As part of our supplier query process, we also make available training materials on the requirements of the Conflict Minerals Rule and the proper procedure to complete the CMRT.

Grievance Mechanism

We have longstanding grievance mechanisms for employees and suppliers to report potential concerns or violations of Abbott policies. These mechanisms include direct reporting to managers or compliance officers, on-line reporting, and a toll-free Helpline that is available 24 hours a day, seven days a week with interpreters available in multiple languages.

3.2                               Identify and Assess Risk in the Supply Chain

We identified and surveyed both direct suppliers and certain sub-suppliers who sell parts, components, or materials likely to contain 3TG. This included identified direct suppliers, as well as lower-tier sub-suppliers who provide parts, components or materials most likely to contain 3TG. We evaluated the responses we received to determine if the response was complete based on internally defined criteria or required further engagement with the supplier. We followed up with suppliers who did not respond, provided an incomplete response, or provided inconsistent data within the CMRT. We have worked, and will continue to work directly with these suppliers to obtain additional information to supplement their responses.

3.3                               Design and Implement a Strategy to Respond to Risks

Abbott’s strategy to respond to identified risks in the supply chain includes the following elements:

·                  We identify potential risks or red flags by evaluating the responses provided by our suppliers, and we have developed processes to address incomplete, inconsistent or otherwise unsatisfactory responses received from our suppliers, including a process to elevate issues to appropriate management for resolution.

·                  We maintain a dashboard to regularly monitor and track our supply chain risk assessment process.

·                  Management is briefed about our due diligence efforts on a regular basis.

3.4                               Carry out Independent Third Party Audit Supply Chain Due Diligence at Identified Points in the Supply Chain

We support audits of 3TG smelters and refiners conducted by third parties through our participation and membership in the CFSI.

3.5                               Report on Supply Chain Due Diligence

This Conflict Minerals Report constitutes our annual report on our 3TG due diligence, is filed with the SEC, and is available on our website at the following link: http://www.abbott.com/policies/conflict-minerals.html

4.                                      Steps to Mitigate Risk

We intend to take (or have taken) the following steps to improve the due diligence conducted on the source and chain of custody of the 3TG in our products:

a)             Participate as a member in the CFSI in efforts to increase the number of smelters and refiners participating in the Conflict-Free Smelter Program.

b)             Engage with suppliers and direct them to training and other resources designed to help them

3

increase the response rate, improve the content of the supplier survey responses, and ensure that the processing facilities they identify are actual, known smelters or refiners.

c)              Evaluate known smelters identified by suppliers that are not actively participating in the Conflict-Free Smelter Program, in an effort to determine the origin of the smelter’s processed minerals.

d)             Work with peer groups and relevant trade associations to define and improve best practices with our supply chain in accordance with the OECD Guidance.

e)              For new or renewed supplier contracts, include a clause requiring the supplier to provide requested information regarding 3TG in the parts, components or materials they supply to Abbott.

5.                                      Determination

For 2014, many suppliers’ responses to our supplier surveys did not include a list of the facilities used to process their 3TGs, in which case we were unable to obtain processing facility information.  A minority of supplier responses listed specific smelters or refiners, with such responses collectively identifying 392 unique facilities, but without specifying which facilities processed the 3TG in the products actually supplied to us. Based on the smelter identification set forth in these responses, we verified 267 unique known smelters from among those listed, of which 135 were certified conflict-free under the Conflict-Free Smelter Program and another 52 were reported to have committed to undergo a Conflict-Free Smelter Program audit. Based on information provided by CFSI, 18 of the certified conflict-free smelters identified by our suppliers were reported to source minerals from the DRC or an adjoining country. As noted, each of those smelters has been certified as conflict-free.  A listing of the known smelters and refiners identified by Abbott’s suppliers is included in Annex I below.

Numerous suppliers also reported some use of 3TG produced from recycled or scrap sources in their supply chain in 2014 but did not provide information on whether any of the parts, components or materials actually supplied to Abbott contained any 3TG from those recycled or scrap sources.

For the reasons set forth above, we were unable to conclusively identify the specific facilities that were used to process the 3TG in the parts, components or materials actually supplied to Abbott or whether the 3TGs were from recycled or scrap sources.

Similarly, based on our due diligence efforts, we do not have sufficient information to conclusively determine the country of origin of the 3TG contained in the parts, components or materials actually supplied to Abbott.

We seek reasonable information about 3TG smelters and refiners and the mines or locations of origin of 3TG in our supply chain through the following efforts:  supporting industry initiatives like the CFSI through our membership; reviewing best practices established in the Organization for Economic Co-operation and Development (OECD) and other due diligence implementation programs; and requesting our suppliers to complete the CMRT, and evaluating supplier responses as described above.

Forward-looking Statements

Please note that forward-looking statements relating to our future plans are based on our current expectations and assumptions, and are not intended to be guarantees. Our actual actions may differ from these forward-looking statements.

4

Annex I